For which patient subgroups are there positive outcomes from a medication review? A systematic review

Keywords: Pharmacists, Community Pharmacy Services, Drug Utilization Review, Multimorbidity, Frail Elderly, Outcome Assessment, Health Care, Systematic Reviews as Topic

Abstract

Background: A medication review is a possibility to assess and optimise a patient’s medicine. A model that includes a medication review and a follow-up seem to provide the best results. However, it is not known whether specific subgroups of patients benefit more from a medication review than others.

Objective: This literature review summarises the evidence that is available on which patient subgroups exist positive outcomes from a medication review carried out in a primary care setting.

Methods: We performed a PICO analysis to identify keywords for setting, medication review and effect. We then conducted a search using the PubMed database (2004 to 2019) to identify studies relevant for our investigation. A screening process was carried out based on either title or abstract, and any study that matched the aim and inclusion criteria was included. All matching studies were obtained and read, and were included if they met predefined criteria such as study design, medication review and primary care. The studies were divided into subgroups. First, each subgroup was divided according to the studies’ own definition. Secondly, each subgroup was allocated as either risk patients if the subgroup described a specific patient subgroup or risk medication, if the subgroup was defined as using a specific type of medication. This was done after discussion in the author group.

Results: 28 studies from a total of 935 studies were included. Identified studies were divided into either risk patients; frail, recently discharged or multimorbid patients, or risk medication; heart medication, antithrombotic medication, blood pressure lowering medication, antidiabetic medication, anti-Parkinson medication or medication increasing the risk of falls. The subgroups identified from a medication review in primary care were defined as being frail, recently discharged from hospital or multimorbid (risk patients), or defined as patients using anticoagulant or blood pressure lowering medication (risk medication). Most of the medication reviews in the studies that showed an economic effect included at least one follow-up and were delivered by a pharmacist.

Conclusions: The literature review demonstrates that medication reviews delivered by pharmacists to specific subgroups of patients are a way of optimising the economic effect of medication reviews in primary care. This is obtained by reducing health-related costs or the number of contacts with primary or secondary health care services.

Downloads

Download data is not yet available.

References

Jódar-Sánchez F, Malet-Larrea A, Martín JJ, García-Mochón L, López Del Amo MP, Martínez-Martínez F, Gastelurrutia-Garralda MA, García-Cárdenas V, Sabater-Hernández D, Sáez-Benito L, Benrimoj SI. Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE program. Pharmacoeconomics. 2015;33(6):599-610. https://doi.org/10.1007/s40273-015-0270-2

Griese-Mammen N, Hersberger KE, Messerli M, Leikola S, Horvat N, van Mil JWF, Kos M. PCNE definition of medication review: reaching agreement. Int J Clin Pharm. 2018;40(5):1199-1208. https://doi.org/10.1007/s11096-018-0696-7

American Pharmacists Association; National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc (2003). 2008;48(3):341-353. https://doi.org/10.1331/japha.2008.08514

Academy of Managed Care Pharmacy. Drug Utilization Review. Availabe at: https://www.amcp.org/about/managed-care-pharmacy-101/concepts-managed-care-pharmacy/drug-utilization-review (accessed on 15/09/2020).

Autralian Government, D.o.H. MedsCheck and Diabetes MedsCheck - Program rules. Available at: https://www.ppaonline.com.au/wp-content/uploads/2019/01/MedsCheck-and-Diabetes-Medscheck-Program-Rules.pdf (accessed on 15/09/2020).

Pharmacy Programs Administrator. MedsCheck and diabetes MedsCheck Service Checklist 1. Available at:https://www.ppaonline.com.au/ (accessed on 15/09/2020).

Ravn-Nielsen LV, Duckert ML, Lund ML, Henriksen JP, Nielsen ML, Eriksen CS, Buck TC, Pottegård A, Hansen MR, Hallas J. Effect of an In-Hospital Multifaceted Clinical Pharmacist Intervention on the Risk of Readmission: A Randomized Clinical Trial. JAMA Intern Med. 2018;178(3):375-382. https://doi.org/10.1001/jamainternmed.2017.8274

Herborg H, Soendergaard B, Froekjaer B, Fonnesbaek L, Jorgensen T, Hepler CD, Grainger-Rousseau TJ, Ersboell BK. Improving drug therapy for patients with asthma--part 1: Patient outcomes. J Am Pharm Assoc (Wash). 2001;41(4):539-550. https://doi.org/10.1016/s1086-5802(16)31278-5

Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43(2):173-184. https://doi.org/10.1331/108658003321480713

Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc (2003). 2006;46(2):133-147. https://doi.org/10.1331/154434506776180658

Bunting BA, Smith BH, Sutherland SE. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc (2003). 2008;48(1):23-31. https://doi.org/10.1331/japha.2008.07140

Bernsten C, Björkman I, Caramona M, Crealey G, Frøkjaer B, Grundberger E, Gustafsson T, Henman M, Herborg H, Hughes C, McElnay J, Magner M, van Mil F, Schaeffer M, Silva S, Søndergaard B, Sturgess I, Tromp D, Vivero L, Winterstein A; Pharmaceutical care of the Elderly in Europe Research (PEER) Group. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging. 2001;18(1):63-77. https://doi.org/10.2165/00002512-200118010-00005

Ocampo CC, Garcia-Cardenas V, Martinez-Martinez F, Benrimoj SI, Amariles P, Gastelurrutia MA. Implementation of medication review with follow-up in a Spanish community pharmacy and its achieved outcomes. Int J Clin Pharm. 2015;37(5):931-940. https://doi.org/10.1007/s11096-015-0145-9

Herborg H, Soendergaard B, Jorgensen T, Fonnesbaek L, Hepler CD, Holst H, Froekjaer B. Improving drug therapy for patients with asthma-part 2: Use of antiasthma medications. J Am Pharm Assoc (Wash). 2001;41(4):551-559. https://doi.org/10.1016/s1086-5802(16)31279-7

Kjeldsen LJ, Bjerrum L, Dam P, Larsen BO, Rossing C, Søndergaard B, Herborg H. Safe and effective use of medicines for patients with type 2 diabetes - A randomized controlled trial of two interventions delivered by local pharmacies. Res Social Adm Pharm. 2015;11(1):47-62. doi:10.1016/j.sapharm.2014.03.003

Rossing C. Agergaard M. El-Souri M. Pultz K. [Evaluation of Medication review with compliance-oriented counseling - a counseling service for heart patients]. Available at: https://hjerteforeningen.dk/wp-content/uploads/2016/11/bilag-evaluering-af-medicingennemgang.pdf (accessed on 15/09/2020).

Björkman IK, Fastbom J, Schmidt IK, Bernsten CB; Pharmaceutical Care of the Elderly in Europe Research (PEER) Group. Drug-drug interactions in the elderly. Ann Pharmacother. 2002;36(11):1675-1681. https://doi.org/10.1345/aph.1a484

Abrahamsen B, Aagaard TL, Rossing C. A protocol for a cost-utility study on medication reviews to elderly polypharmacy patients at the community pharmacy. Availabe at: https://www.pcne.org/script25.php?abstractid=157 (accessed on Sep 15, 2020).

9th Nordic Social Pharmacy Conference 2019 - Conference abstracts. Res Social Adm Pharm. 2019;15(12):e41-e55, doi: https://doi.org/10.1016/j.sapharm.2019.09.006

Abstracts PCNE working conference 2017. Bled, Slovenia. 1–3 February 2017. Int J Clin Pharm. 2017;39(3):601-626, https://doi.org/10.1007/s11096-017-0462-2

Joanna Briggs Institute. Critical Appraisal Checklist for Randomized Controlled Trials. Available at: https://joannabriggs.org/sites/default/files/2020-08/Checklist_for_RCTs.pdf (accessed on Sep 15, 2020).

Joanna Briggs Institute. Critical appraisal checklist for cohort studies. Available at: https://joannabriggs.org/sites/default/files/2020-08/Checklist_for_Cohort_Studies.pdf (accessed on Sep 15, 2020).

Joanna Briggs Institute. Critical Appraisal Checklist for Quasi-Experimental Studies. Available at: https://joannabriggs.org/sites/default/files/2020-08/Checklist_for_Quasi-Experimental_Appraisal_Tool.pdf (accessed on Sep 15, 2020).

Joanna Briggs Institute. JBI critical appraisal checklist for case control studies. Available at: https://joannabriggs.org/sites/default/files/2020-08/Checklist_for_Case_Control_Studies.pdf (accessed on Sep 15, 2020).

Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097

Mott DA, Martin B, Breslow R, Michaels B, Kirchner J, Mahoney J, Margolis A. Impact of a medication therapy management intervention targeting medications associated with falling: Results of a pilot study. J Am Pharm Assoc (2003). 2016;56(1):22-28. https://doi.org/10.1016/j.japh.2015.11.001

Geurts MM, Stewart RE, Brouwers JR, de Graeff PA, de Gier JJ. Implications of a clinical medication review and a pharmaceutical care plan of polypharmacy patients with a cardiovascular disorder. Int J Clin Pharm. 2016;38(4):808-815. https://doi.org/10.1007/s11096-016-0281-x

Roughead EE, Barratt JD, Ramsay E, Pratt N, Ryan P, Peck R, Killer G, Gilbert AL. Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veterans. J Clin Pharm Ther. 2011;36(1):27-32. https://doi.org/10.1111/j.1365-2710.2009.01149.x

Stafford L, Peterson GM, Bereznicki LR, Jackson SL, van Tienen EC, Angley MT, Bajorek BV, McLachlan AJ, Mullan JR, Misan GM, Gaetani L. Clinical outcomes of a collaborative, home-based postdischarge warfarin management service. Ann Pharmacother. 2011;45(3):325-334. https://doi.org/10.1345/aph.1p617

Wittayanukorn S, Westrick SC, Hansen RA, Billor N, Braxton-Lloyd K, Fox BI, Garza KB. Evaluation of medication therapy management services for patients with cardiovascular disease in a self-insured employer health plan. J Manag Care Pharm. 2013;19(5):385-395. https://doi.org/10.18553/jmcp.2013.19.5.385

Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc (2003). 2009;49(2):164-170. https://doi.org/10.1331/japha.2009.08164

Skinner JS, Poe B, Hopper R, Boyer A, Wilkins CH. Assessing the effectiveness of pharmacist-directed medication therapy management in improving diabetes outcomes in patients with poorly controlled diabetes. Diabetes Educ. 2015;41(4):459-465. https://doi.org/10.1177/0145721715587563

Brummel AR, Soliman AM, Carlson AM, de Oliveira DR. Optimal diabetes care outcomes following face-to-face medication therapy management services. Popul Health Manag. 2013;16(1):28-34. https://doi.org/10.1089/pop.2012.0023

Krass I, Taylor SJ, Smith C, Armour CL. Impact on medication use and adherence of Australian pharmacists' diabetes care services. J Am Pharm Assoc (2003). 2005;45(1):33-40. https://doi.org/10.1331/1544345052843093

Foppa AA, Chemello C, Vargas-Peláez CM, Farias MR. Medication Therapy Management Service for Patients with Parkinson's Disease: A Before-and-After Study. Neurol Ther. 2016;5(1):85-99. https://doi.org/10.1007/s40120-016-0046-4

Henrichsmann M, Hempel G. Impact of medication therapy management in patients with Parkinson's disease. Int J Clin Pharm. 2016;38(1):54-60. https://doi.org/10.1007/s11096-015-0206-0

Wouters H, Scheper J, Koning H, Brouwer C, Twisk JW, van der Meer H, Boersma F, Zuidema SU, Taxis K. Discontinuing Inappropriate Medication Use in Nursing Home Residents: A Cluster Randomized Controlled Trial. Ann Intern Med. 2017;167(9):609-617. https://doi.org/10.7326/m16-2729

Moore JM, Shartle D, Faudskar L, Matlin OS, Brennan TA. Impact of a patient-centered pharmacy program and intervention in a high-risk group. J Manag Care Pharm. 2013;19(3):228-236. https://doi.org/10.18553/jmcp.2013.19.3.228

Verrue C, Mehuys E, Boussery K, Adriaens E, Remon JP, Petrovic M. A pharmacist-conducted medication review in nursing home residents: impact on the appropriateness of prescribing. Acta Clin Belg. 2012;67(6):423-429. https://doi.org/10.2143/acb.67.6.2062707

Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care--the POLYMED randomised controlled trial. Age Ageing. 2007;36(3):292-297. https://doi.org/10.1093/ageing/afm036

Zermansky AG, Alldred DP, Petty DR, Raynor DK, Freemantle N, Eastaugh J, Bowie P. Clinical medication review by a pharmacist of elderly people living in care homes--randomised controlled trial. Age Ageing. 2006;35(6):586-591. https://doi.org/10.1093/ageing/afl075

Leendertse AJ, de Koning GH, Goudswaard AN, Belitser SV, Verhoef M, de Gier HJ, Egberts AC, van den Bemt PM. Preventing hospital admissions by reviewing medication (PHARM) in primary care: an open controlled study in an elderly population. J Clin Pharm Ther. 2013;38(5):379-387. https://doi.org/10.1111/jcpt.12069

Verdoorn S, Kwint HF, Blom JW, Gussekloo J, Bouvy ML. Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: A randomised controlled trial (DREAMeR-study). PLoS Med. 2019;16(5):e1002798. https://doi.org/10.1371/journal.pmed.1002798

Lapointe-Shaw L, Bell CM, Austin PC, Abrahamyan L, Ivers NM, Li P, Pechlivanoglou P, Redelmeier DA, Dolovich L. Community pharmacy medication review, death and re-admission after hospital discharge: a propensity score-matched cohort study. BMJ Qual Saf. 2020;29(1):41-51. https://doi.org/10.1136/bmjqs-2019-009545

Shaya FT, Chirikov VV, Rochester C, Zaghab RW, Kucharski KC. Impact of a comprehensive pharmacist medication-therapy management service. J Med Econ. 2015;18(10):828-837. https://doi.org/10.3111/13696998.2015.1052463

Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, Christou M, Evans D, Hand C. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ. 2005;330(7486):293. https://doi.org/10.1136/bmj.38338.674583.ae

Ferries E, Dye JT, Hall B, Ndehi L, Schwab P, Vaccaro J. Comparison of Medication Therapy Management Services and Their Effects on Health Care Utilization and Medication Adherence. J Manag Care Spec Pharm. 2019;25(6):688-695. https://doi.org/10.18553/jmcp.2019.25.6.688

Isetts BJ, Schondelmeyer SW, Artz MB, Lenarz LA, Heaton AH, Wadd WB, Brown LM, Cipolle RJ. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc (2003). 2008;48(2):203-211. https://doi.org/10.1331/japha.2008.07108

Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial [published correction appears in Br J Clin Pharmacol. 2005 Mar;59(3):376]. Br J Clin Pharmacol. 2004;58(6):648-664. https://doi.org/10.1111/j.1365-2125.2004.02220.x

Roughead EE, Barratt JD, Ramsay E, Pratt N, Ryan P, Peck R, Killer G, Gilbert AL. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circ Heart Fail. 2009;2(5):424-428. https://doi.org/10.1161/circheartfailure.109.861013

Messerli M, Vriends N, Hersberger KE. Humanistic outcomes and patient acceptance of the pharmacist-led medication review "Polymedication Check" in primary care in Switzerland: a prospective randomized controlled trial. Patient Prefer Adherence. 2018;12:1071-1078. https://doi.org/10.2147/ppa.s160789

Messerli M, Blozik E, Vriends N, Hersberger KE. Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy--a prospective randomised controlled trial. BMC Health Serv Res. 2016;16:145. https://doi.org/10.1186/s12913-016-1384-8

Messerli M. Clinical pharmacy services and evaluation of medicines use: the case of the swiss polymedication check. Available at: https://edoc.unibas.ch/43734/ (accessed on Sep 15, 2020).

PCNE working conference 2019. How to find the right patients for specific pharmacy services? Available at: https://www.pcne.org/upload/files/311_WS2_report_extended.pdf (accessed on Sep 15, 2020).

Published
2020-10-27
How to Cite
1.
Abrahamsen B, Hansen RN, Rossing C. For which patient subgroups are there positive outcomes from a medication review? A systematic review. Pharm Pract (Granada) [Internet]. 2020Oct.27 [cited 2020Nov.28];18(4):1976. Available from: https://pharmacypractice.org/journal/index.php/pp/article/view/1976
Section
Original Research

Most read articles by the same author(s)